051630 — CHINYANG CHEMICAL Income Statement
0.000.00%
- KR₩48bn
- KR₩60bn
- KR₩19bn
Annual income statement for CHINYANG CHEMICAL, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 34,785 | 29,090 | 28,281 | 24,527 | 18,564 |
| Cost of Revenue | |||||
| Gross Profit | 728 | 2,666 | 2,697 | 236 | 1,634 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 38,775 | 30,146 | 30,494 | 28,733 | 19,307 |
| Operating Profit | -3,990 | -1,056 | -2,212 | -4,205 | -743 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -1,564 | -1,239 | -2,192 | -4,488 | 789 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2,213 | -1,113 | -2,171 | -4,488 | 896 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -2,213 | -1,113 | -2,171 | -4,488 | 896 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2,213 | -1,113 | -2,171 | -4,488 | 896 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -251 | -60.9 | -122 | -267 | 42.6 |
| Dividends per Share |